Bench to Bedside: Focus on RNA Therapeutics
Thursday • May 8, 2025 • 8:30–10:00 AM
Moderator: Jenny Lam, Ph.D., University College London, UK
Addressing the Challenge of Respiratory RNA Therapeutics with Inhalable Hybrid Lipid-Polymer Nanoparticles
Francesca Ungaro
University of Napoli Federico
University of Napoli Federico
A Non-Lipid Nanoparticle Platform for Targeted RNA Therapeutic Delivery
Jag Shur
RIGImmune
RIGImmune
Discover More
Poly (ADP-Ribose) Polymerase Inhibition as a Treatment Option for Pulmonary Fibrosis
Rob Bischof
Federation University
Federation University
Advancing High-Dosage Dry Powder Inhaler Formulations: Integrating Quality by Design for Optimized Performance
Rui Churro
Hovione
Hovione
Distinct Baseline Phenotypical and Functional Properties of Macrophages Derived from Two Different Lots of THP-1 Monocytes for Screening the Effects of Inhalable Drugs
Alexandre Ribeiro and Mykaella Mestre
Hovione
Hovione
Design, Development, and Validation of a Novel Dry Powder Inhaler Adaptor for Increased Deposition of Anti-Inflammatory Agents in Pediatric Asthma
Lily Zhu
Johns Hopkins University
Johns Hopkins University
Inhalable Spray-Dried Lipid Nanoparticles for Pulmonary siRNA Delivery
Leonie Deßloch
Ludwig-Maximilians-University Munich
Ludwig-Maximilians-University Munich
Bulk Excipient Screening of a Spray Dried Glucagon-Like Peptide 1 Receptor Agonist Formulation
Stefania Glieca and Irene Rossi
University of Parma
University of Parma
Lactobacilli Inhalation Powders as Antibacterial Agents against S. Aureus
Stefania Glieca
University of Parma
University of Parma
In Vivo Deposition and Retention of Ciprofloxacin Liposomal Dry Powder Aerosol
Rudra Pangeni and Michael Hindle
Virginia Commonwealth University
Virginia Commonwealth University
CO-ORGANIZERS
CONFERENCE SUPPORTERS
